Bravera Control
Bravera Control
Bravera Control contains lidocaine, a substance which has been commonly used in medicine for many years. Bravera Control in the form of skin aerosol, a solution, provides a local anesthetic effect, reducing the sensitivity of the penis to touch.
It is the first and only drug on the Polish market available in pharmacies without a prescription, dedicated to the treatment of premature ejaculation[1].
[1] The URPL data according to http://pub.rejestrymedyczne.csioz.gov.pl search engine, as of 28th April 2020.
Pharmaceutical form
aerosol. 8 ml
Kategoria
OTC
Additional information
Recommended dosage is 3 to 7 pump presses, made to cover the stem and root of the penis, applied 5 to 15 minutes before intercourse. If after 5 minutes there is an excess of the drug on the penis, it should be removed before intercourse. The amount and time of application should be selected according to individual needs. Always use the smallest effective dose. There should be an interval of at least 4 hours between application of successive doses. Do not exceed the dose of 22 pump presses within 24 hours.
The drug should not be used for more than 1 month without doctor supervision.
Active substance
1 g of the spray contains 96 mg of lidocaine.
Each press of the spray pump provides 0.085 ml of the solution (which corresponds to 81.98 mg of aerosol containing 7.87 mg of lidocaine).
Indications
The drug is indicated for use before intercourse in case of premature ejaculation in order to reduce penis sensitivity to touch and delay ejaculation.
Contraindications
Hypersensitivity of the patient or his/her partner to the active substance, other amide topical anaesthetics or to any of the excipients.
Pregnancy of the patient's partner.
Damaged or inflamed skin.
Marketing Authorisation Holder
Aflofarm Farmacja Polska Spółka z o.o.
Marketing Authorisation
25237
